Chou Associates Management
13F Holdings and Portfolio Analysis
Francis Chou 2017 Q1 13F holdings, quarterly changes, portfolio value trend and position weight distribution.
Chou Associates Management Overview
Chou Associates Management held 27 stocks in 2017 Q1, with total market value around $0.30B.
Chou Associates Management's top five holdings in 2017 Q1: BERKSHIRE HATHAWAY INC CL A(BRK.A) 12.43%, JPMORGAN CHASE & CO 9.62%, RESOLUTE FST PRODS INC 8.97%, VALEANT PHARMACEUTICALS INTL 8.61%, Citigroup Inc.(C) 8.14%.
- Portfolio Value
- $0.30B
- Current Holdings
- 27 stocks
- New / Increased
- 2 / 2
- Reduced / Exited
- 4 / 3
Current Holdings
| 1 | BERKSHIRE HATHAWAY INC CL ABRK.A | 0.04 | 12.43% | 0.00 - | $249853.33 | $705400.23 +182.33% | $168600.00 | 0.00 | 4.00 | +$0.08B+318.39% | Held |
| 2 | JPMORGAN CHASE & COCUSIP 46634E114 | 0.03 | 9.62% | 0.63 -44.39% | $46.31 | - | $20.81 | -0.50 | 2.50 | +$0.02B+122.56% | Reduced |
| 3 | RESOLUTE FST PRODS INCCUSIP 76117W109 | 0.03 | 8.97% | 4.96 - | $5.45 | - | $12.15 | 0.00 | 4.00 | -$0.03B-55.16% | Held |
| 4 | VALEANT PHARMACEUTICALS INTLCUSIP 91911K102 | 0.03 | 8.61% | 2.35 +20.04% | $11.03 | - | $15.80 | +0.39 | 1.25 | -$0.01B-30.21% | Increased |
| 5 | Citigroup Inc.C | 0.02 | 8.14% | 0.41 - | $59.82 | $97.52 +63.02% | $47.97 | 0.00 | 4.00 | +$0.02B+103.29% | Held |
| 6 | WELLS FARGO & CO NEWCUSIP 949746119 | 0.02 | 7.34% | 1.00 - | $22.19 | - | $13.67 | 0.00 | 4.00 | +$0.01B+62.33% | Held |
| 7 | SanofiSNY | 0.02 | 6.16% | 0.41 - | $45.25 | $49.22 +8.77% | $51.51 | 0.00 | 4.00 | -$0.00B-4.45% | Held |
| 8 | The Goldman Sachs Group, Inc.GS | 0.02 | 5.72% | 0.07 - | $229.72 | $751.53 +227.15% | $151.25 | 0.00 | 4.00 | +$0.05B+396.87% | Held |
| 9 | NOKIA OYJ COMMON STOCKNOK | 0.01 | 4.94% | 2.75 -26.67% | $5.42 | - | $3.74 | -1.00 | 4.00 | +$0.00B+44.92% | Reduced |
| 10 | SEARS HLDGS CORPCUSIP 812350106 | 0.01 | 4.31% | 1.13 - | $11.49 | - | $26.53 | 0.00 | 4.00 | -$0.02B-56.69% | Held |
| 11 | ENDO INTL PLCCUSIP G30401106 | 0.01 | 3.52% | 0.95 | $11.16 | - | $11.16 | +0.95 | 0.25 | $0.00B0.00% | New |
| 12 | OVERSTOCK COM INC DELCUSIP 690370101 | 0.01 | 3.32% | 0.58 - | $17.20 | - | $28.20 | 0.00 | 4.00 | -$0.01B-39.01% | Held |
| 13 | MBIA INC COMMBI | 0.01 | 3.04% | 1.08 - | $8.47 | - | $13.31 | 0.00 | 4.00 | -$0.01B-36.36% | Held |
| 14 | Teva Pharmaceutical Industries LimitedTEVA | 0.01 | 2.29% | 0.21 | $32.09 | $20.11 -37.33% | $32.09 | +0.21 | 0.25 | -$0.00B-37.33% | New |
| 15 | BANK AMER CORPCUSIP 060505146 | 0.01 | 2.01% | 0.54 -35.85% | $11.30 | - | $5.46 | -0.30 | 4.00 | +$0.00B+106.96% | Reduced |
| 16 | SEARS HOMETOWN & OUTLET STORCUSIP 812362101 | 0.01 | 1.71% | 1.32 - | $3.90 | - | $11.59 | 0.00 | 2.75 | -$0.01B-66.35% | Held |
| 17 | ASCENT CAP GROUP INCCUSIP 043632108 | 0.00 | 1.43% | 0.31 - | $14.13 | - | $15.39 | 0.00 | 1.00 | -$0.00B-8.19% | Held |
| 18 | BLACKBERRY LTD COMBB | 0.00 | 1.36% | 0.53 - | $7.75 | - | $7.89 | 0.00 | 3.75 | -$0.00B-1.86% | Held |
| 19 | SANDRIDGE ENERGY INCSD | 0.00 | 0.96% | 0.16 +224.67% | $18.49 | - | $20.05 | +0.11 | 0.50 | -$0.00B-7.77% | Increased |
| 20 | COMPUCREDIT HLDGS CORPCUSIP 20478NAD2 | 0.00 | 0.94% | 5.80 -25.64% | $0.49 | - | $0.44 | -2.00 | 1.00 | +$0.00B+11.09% | Reduced |
| 21 | CHICAGO BRIDGE & IRON CO N V N Y REGISTRY SHCBI | 0.00 | 0.69% | 0.07 - | $30.75 | - | $34.64 | 0.00 | 1.00 | -$0.00B-11.22% | Held |
| 22 | ASCENT CAPITAL GROUP INC CV SR UNSEC NTCUSIP 043632AA6可转换债券 | 0.00 | 0.69% | 2.68 - | $0.77 | - | $1.01 | 0.00 | 2.75 | -$0.00B-24.13% | Held |
| 23 | RYANAIR HOLDINGS PLC SPONSORED ADSRYAAY | 0.00 | 0.46% | 0.02 - | $82.96 | - | $86.46 | 0.00 | 1.50 | -$0.00B-4.05% | Held |
| 24 | China Yuchai International LimitedCYD | 0.00 | 0.45% | 0.07 - | $18.51 | $34.95 +88.81% | $5.87 | 0.00 | 4.00 | +$0.00B+495.02% | Held |
| 25 | POSCO HOLDINGS INC -SPON ADRPKX | 0.00 | 0.45% | 0.02 - | $64.52 | - | $35.05 | 0.00 | 1.75 | +$0.00B+84.10% | Held |
Showing 1-25 of 27
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.
Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.
Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.
Exited Holdings
Stocks no longer disclosed in the current 13F portfolio for 2017 Q1.
| 1 | SANDRIDGE ENERGY INCCUSIP 80007PBC2 | 2.03 | 0.25 | $1.25 | $1.25 | $0.00B0.00% |
| 2 | AstraZeneca PLCAZN | 0.01 | 3.25 | $58.92 | $54.69 | -$0.00B-7.18% |
| 3 | GSK plcGSK | 0.02 | 3.25 | $26.56 | $19.28 | -$0.00B-27.41% |
Showing 1-3 of 3
Exited holdings are stocks disclosed in the previous report period but no longer disclosed in the current 13F portfolio.
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis uses the same weighted cost-pool method as current holdings. Estimated exit price uses the current report period weighted report price when available, otherwise the previous report price; it does not represent the actual sale price.
Exit return shows estimated dollar return on top and percentage return below.
Portfolio Visuals
Track portfolio value, position weights and Top 10 history.